Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) today announced the promotion of Dr. Ganesh Kaundinya to Chief Operating Officer. Dr. Kaundinya, who ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Management Changes Management Comments

Momenta Pharmaceuticals (MNTA) PT Lowered to $16 at Barclays; 'More Conservative Stance on Eventual (Generic Copaxone 40mg) Market Share'October 4, 2017 12:02 PM Momenta Pharmaceuticals Promotes Ganesh V. Kaundinya as Chief Operating Officer and Chief Scientific OfficerOctober 2, 2017 4:05 PM UPDATE: Goldman Sachs Starts Momenta Pharmaceuticals (MNTA) at NeutralSeptember 28, 2017 6:51 AM